Quipt Home Medical Corp. (QIPT)

Quipt Home Medical Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Net Income	-10.67	-10.7	-6.76	-2.78	4.84	-6.17
Depreciation & Amortization	53.81	51.92	50.56	41.23	23.04	17.79
Other Amortization	0.53	0.56	0.55	0.59	0.25	0.18
Loss (Gain) From Sale of Assets	-1.28	-1.23	-0.11	-0.08	0.05	-0.09
Loss (Gain) on Equity Investments	0.29	0.32	0.31	0.09	-	-
Stock-Based Compensation	4.81	4.04	2.48	5.28	5.49	4.95
Other Operating Activities	-6.41	-6.14	-3.99	-5.34	-8.08	2.3
Change in Accounts Receivable	0.88	2.58	-3.29	-3.06	-0.2	-0.87
Change in Inventory	-4.49	-2.42	-3.42	-0.06	-2.42	-0.09
Change in Accounts Payable	-1.5	-3.41	3.13	3.12	2.9	0.3
Change in Unearned Revenue	-0.15	-0.02	-0.94	0.24	0.03	0.33
Change in Other Net Operating Assets	1.16	2.19	-3.12	-2.24	0.45	-0.86
Operating Cash Flow	37.33	37.69	35.38	36.98	26.34	17.76
Operating Cash Flow Growth	9.56%	6.53%	-4.32%	40.37%	48.33%	26.56%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Capital Expenditures	-10.75	-12.35	-10.31	-6.85	-9.16	-5.05
Sale of Property, Plant & Equipment	1.33	1.23	0.21	0.07	0.19	0.1
Cash Acquisitions	-21.82	-21.82	-0.21	-76.04	-33.53	-12.89
Investing Cash Flow	-31.25	-32.95	-10.31	-82.83	-42.49	-17.84

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Long-Term Debt Issued	-	35.65	17.1	80.5	12	-
Long-Term Debt Repaid	-	-43.2	-42.6	-47.42	-15.72	-12.96
Net Debt Issued (Repaid)	-12.12	-7.55	-25.5	33.08	-3.72	-12.96
Issuance of Common Stock	0.63	-	0.57	28.35	0.57	19.08
Repurchase of Common Stock	-0.13	-0.13	-0.21	-1.34	-	-
Other Financing Activities	-0.05	-0.08	-1	-5.66	-6.7	-1.27
Financing Cash Flow	-11.68	-7.76	-26.15	54.43	-9.85	4.84

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Foreign Exchange Rate Adjustments	0.68	-0.25	0.04	0.11	-0.1	0.62
Net Cash Flow	-4.91	-3.26	-1.04	8.69	-26.1	5.39

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Free Cash Flow	26.59	25.34	25.07	30.13	17.18	12.72
Free Cash Flow Growth	22.79%	1.08%	-16.79%	75.34%	35.14%	-8.81%
Free Cash Flow Margin	10.03%	10.33%	10.19%	14.23%	13.46%	13.47%
Free Cash Flow Per Share	0.61	0.58	0.59	0.78	0.47	0.42
Levered Free Cash Flow	44.54	41.54	31.27	35.76	14.75	14.05
Unlevered Free Cash Flow	48.61	44.91	35.9	38.86	15.8	15.12

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash Interest Paid	6.02	5.91	6.83	6.03	-	-
Cash Income Tax Paid	-	-0.43	1.25	0.68	0.65	-
Change in Working Capital	-4.09	-1.08	-7.65	-2.01	0.76	-1.19

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error